Test ID: HIT
Heparin-PF4 Antibody (HIT), Serum
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
Useful For Suggests clinical disorders or settings where the test may be helpful
Evaluation of possible immune-mediated Type II (HIT-II), which should be suspected for the following patients:
-Patients not previously exposed to heparin, the development of absolute thrombocytopenia or decrease in platelet count of > or =50% from baseline or postoperative peak with the onset of thrombocytopenia beginning approximately 5 to 10 days after initiation of heparin. This may or may not be associated with new or progressive thrombosis in patients treated with heparin.
-Patients previously exposed to heparin (especially within the preceding 100 days), in addition to the above findings, the onset of thrombocytopenia could occur within 24 to 48 hours after reexposure to heparin.
In patients with prior suspected or documented heparin-induced thrombocytopenia (HIT), with or without thrombosis, assay for presence of H/PF4 antibody may be useful in assessment of the risk of recurrence of HIT with additional exposure to heparin, however, prospective data are limited.
Method Name A short description of the method used to perform the test
Enzyme-Linked Immunosorbent Assay (ELISA)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Aliases Lists additional common names for a test, as an aid in searching
Heparin Induced Antibody
Heparin-Dependent Antibody
HIT ELISA
PF4 ELISA
External
link
PDF
document
Excel
document
Word
document